Financhill
Sell
38

H Quote, Financials, Valuation and Earnings

Last price:
$121.52
Seasonality move :
-3.09%
Day range:
$120.64 - $123.87
52-week range:
$102.43 - $168.20
Dividend yield:
0.49%
P/E ratio:
15.87x
P/S ratio:
1.85x
P/B ratio:
3.37x
Volume:
1.1M
Avg. volume:
1M
1-year change:
-18.8%
Market cap:
$11.7B
Revenue:
$6.6B
EPS (TTM):
$7.70
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Revenue $2.1B $3B $5.9B $6.7B $6.6B
Revenue Growth (YoY) -58.85% 46.56% 94.55% 13.17% -0.29%
 
Cost of Revenues $2.1B $2.6B $4.6B $5.4B $5.4B
Gross Profit -$1M $425M $1.3B $1.3B $1.3B
Gross Profit Margin -0.05% 14.04% 21.86% 19.59% 19.51%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $321M $366M $435M $578M $548M
Other Inc / (Exp) -$230M $452M $42M $50M $1.2B
Operating Expenses $631M $698M $861M $975M $881M
Operating Income -$632M -$273M $427M $331M $416M
 
Net Interest Expenses $98M $135M $106M $71M $57M
EBT. Incl. Unusual Items -$960M $44M $363M $310M $1.6B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -$257M $266M -$92M $90M $267M
Net Income to Company -$703M -$222M $455M $220M $1.3B
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$703M -$222M $455M $220M $1.3B
 
Basic EPS (Cont. Ops) -$6.93 -$2.13 $4.17 $2.10 $12.99
Diluted EPS (Cont. Ops) -$6.93 -$2.13 $4.09 $2.05 $12.65
Weighted Average Basic Share $101.3M $104M $109.1M $104.9M $99.8M
Weighted Average Diluted Share $101.3M $104M $111.3M $107.7M $102.4M
 
EBITDA -$491M $544M $974M $894M $2.1B
EBIT -$832M $207M $513M $455M $1.7B
 
Revenue (Reported) $2.1B $3B $5.9B $6.7B $6.6B
Operating Income (Reported) -$632M -$273M $427M $331M $416M
Operating Income (Adjusted) -$832M $207M $513M $455M $1.7B
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Revenue $438M $1.3B $1.7B $1.7B $1.7B
Revenue Growth (YoY) -55.89% 192.01% 31.35% 2.02% 0.23%
 
Cost of Revenues $424M $1B $1.3B $1.4B $1.4B
Gross Profit $14M $252M $335M $309M $332M
Gross Profit Margin 3.2% 19.7% 19.94% 18.03% 19.33%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $95M $111M $157M $169M $126M
Other Inc / (Exp) $72M -$59M $23M $509M -$33M
Operating Expenses $169M $230M $255M $261M $216M
Operating Income -$155M $22M $80M $48M $116M
 
Net Interest Expenses $35M $34M -- $16M $31M
EBT. Incl. Unusual Items -$118M -$71M $105M $541M $52M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $186M $2M $47M $19M $28M
Net Income to Company -$304M -$73M $58M $522M $24M
 
Minority Interest in Earnings -- -- -- -- -$4M
Net Income to Common Excl Extra Items -$304M -$73M $58M $522M $20M
 
Basic EPS (Cont. Ops) -$2.99 -$0.67 $0.55 $5.08 $0.20
Diluted EPS (Cont. Ops) -$2.99 -$0.67 $0.53 $4.93 $0.19
Weighted Average Basic Share $101.5M $110.2M $106.4M $102.8M $96M
Weighted Average Diluted Share $101.5M $110.2M $108.9M $105.9M $98.1M
 
EBITDA $5M $97M $245M $681M $206M
EBIT -$77M -$31M $138M $579M $118M
 
Revenue (Reported) $438M $1.3B $1.7B $1.7B $1.7B
Operating Income (Reported) -$155M $22M $80M $48M $116M
Operating Income (Adjusted) -$77M -$31M $138M $579M $118M
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Revenue $1.5B $3.9B $6.3B $6.7B $6.7B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $1.6B $3.2B $4.9B $5.4B $5.3B
Gross Profit -$119M $663M $1.4B $1.3B $1.3B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $369M $382M $481M $592M $505M
Other Inc / (Exp) -$21M $319M $123M $520M $664M
Operating Expenses $673M $757M $885M $983M $838M
Operating Income -$792M -$94M $486M $297M $482M
 
Net Interest Expenses $127M $134M $70M $71M $72M
EBT. Incl. Unusual Items -$940M $91M $539M $746M $1.1B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -$36M $82M -$47M $62M $276M
Net Income to Company -$904M $9M $586M $684M $798M
 
Minority Interest in Earnings -- -- -- -- -$4M
Net Income to Common Excl Extra Items -$904M $9M $586M $684M $794M
 
Basic EPS (Cont. Ops) -$8.91 $0.16 $5.42 $6.63 $7.92
Diluted EPS (Cont. Ops) -$8.91 $0.14 $5.32 $6.44 $7.70
Weighted Average Basic Share
Weighted Average Diluted Share
 
EBITDA -$453M $636M $1.1B $1.3B $1.6B
EBIT -$788M $253M $682M $896M $1.3B
 
Revenue (Reported) $1.5B $3.9B $6.3B $6.7B $6.7B
Operating Income (Reported) -$792M -$94M $486M $297M $482M
Operating Income (Adjusted) -$788M $253M $682M $896M $1.3B
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Revenue $438M $1.3B $1.7B $1.7B $1.7B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $424M $1B $1.3B $1.4B $1.4B
Gross Profit $14M $252M $335M $309M $332M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $95M $111M $157M $169M $126M
Other Inc / (Exp) $72M -$59M $23M $509M -$33M
Operating Expenses $169M $230M $255M $261M $216M
Operating Income -$155M $22M $80M $48M $116M
 
Net Interest Expenses $35M $34M -- $16M $31M
EBT. Incl. Unusual Items -$118M -$71M $105M $541M $52M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $186M $2M $47M $19M $28M
Net Income to Company -$304M -$73M $58M $522M $24M
 
Minority Interest in Earnings -- -- -- -- -$4M
Net Income to Common Excl Extra Items -$304M -$73M $58M $522M $20M
 
Basic EPS (Cont. Ops) -$2.99 -$0.67 $0.55 $5.08 $0.20
Diluted EPS (Cont. Ops) -$2.99 -$0.67 $0.53 $4.93 $0.19
Weighted Average Basic Share $101.5M $110.2M $106.4M $102.8M $96M
Weighted Average Diluted Share $101.5M $110.2M $108.9M $105.9M $98.1M
 
EBITDA $5M $97M $245M $681M $206M
EBIT -$77M -$31M $138M $579M $118M
 
Revenue (Reported) $438M $1.3B $1.7B $1.7B $1.7B
Operating Income (Reported) -$155M $22M $80M $48M $116M
Operating Income (Adjusted) -$77M -$31M $138M $579M $118M
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Cash and Equivalents $1.2B $960M $991M $881M $1B
Short Term Investments $675M $227M $158M $15M $372M
Accounts Receivable, Net $316M $633M $834M $883M $1.1B
Inventory $9M $10M $9M $9M $8M
Prepaid Expenses $281M $26M $39M $51M $46M
Other Current Assets $64M $149M $180M $195M $174M
Total Current Assets $2.6B $2.1B $2.3B $2.1B $2.7B
 
Property Plant And Equipment $3.6B $3.3B $2.8B $2.7B $2B
Long-Term Investments $980M $954M $833M $993M $1.3B
Goodwill $288M $3B $3.1B $3.2B $2.5B
Other Intangibles $385M $2B $1.7B $1.7B $2.2B
Other Long-Term Assets $1.1B $1.3B $1.3B $1.5B $1.7B
Total Assets $9.1B $12.6B $12.3B $12.8B $13.3B
 
Accounts Payable $102M $523M $500M $493M $475M
Accrued Expenses $200M $299M $415M $468M $565M
Current Portion Of Long-Term Debt $260M $10M $660M $751M $456M
Current Portion Of Capital Lease Obligations $29M $35M $39M $41M $33M
Other Current Liabilities -- -- -- $17M --
Total Current Liabilities $984M $2.2B $3.3B $3.6B $3.3B
 
Long-Term Debt $3B $4B $2.5B $2.3B $3.3B
Capital Leases -- -- -- -- --
Total Liabilities $5.9B $9B $8.6B $9.3B $9.5B
 
Common Stock $1M $1M $1M $1M $1M
Other Common Equity Adj -$192M -$245M -$242M -$175M -$269M
Common Equity $3.2B $3.6B $3.7B $3.6B $3.5B
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $3M $3M $3M $3M $279M
Total Equity $3.2B $3.6B $3.7B $3.6B $3.8B
 
Total Liabilities and Equity $9.1B $12.6B $12.3B $12.8B $13.3B
Cash and Short Terms $1.9B $1.2B $1.1B $896M $1.4B
Total Debt $3.2B $4B $3.1B $3.1B $3.8B
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Cash and Equivalents $1.1B $1B $948M $740M $1.7B
Short Term Investments $550M $282M $103M $54M $70M
Accounts Receivable, Net $340M $655M $828M $895M $1.2B
Inventory $9M $8M $10M $9M $8M
Prepaid Expenses $288M $53M $36M $58M $62M
Other Current Assets $58M $154M $205M $193M $168M
Total Current Assets $2.3B $2.6B $2.2B $2B $3.3B
 
Property Plant And Equipment $3.6B $2.9B $2.8B $2.6B $2B
Long-Term Investments $1B $908M $915M $1.2B $1.4B
Goodwill $288M $3B $3.1B $2.3B $2.5B
Other Intangibles $378M $1.9B $1.8B $1.6B $2.3B
Other Long-Term Assets $1.1B $1.3B $1.4B $1.5B $1.7B
Total Assets $8.8B $12.7B $12.6B $11.7B $14B
 
Accounts Payable $102M $546M $544M $539M $560M
Accrued Expenses $180M $317M $475M $439M $629M
Current Portion Of Long-Term Debt $260M $6M $648M $751M $406M
Current Portion Of Capital Lease Obligations $27M $35M $39M $37M $34M
Other Current Liabilities -- $212M -- $7M --
Total Current Liabilities $950M $2.5B $3.3B $3.4B $3.3B
 
Long-Term Debt $3B $3.8B $2.5B $2.3B $3.9B
Capital Leases -- -- -- -- --
Total Liabilities $5.9B $9.2B $8.9B $8.1B $10.2B
 
Common Stock $1M $1M $1M $1M $1M
Other Common Equity Adj -$237M -$231M -$223M -$197M -$224M
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $3M $3M $3M $3M $301M
Total Equity $2.9B $3.5B $3.7B $3.7B $3.8B
 
Total Liabilities and Equity $8.8B $12.7B $12.6B $11.7B $14B
Cash and Short Terms $1.6B $1.3B $1.1B $794M $1.8B
Total Debt $3.2B $3.8B $3.1B $3.1B $4.3B
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Net Income to Stockholders -$703M -$222M $455M $220M $1.3B
Depreciation & Amoritzation $341M $337M $461M $439M $369M
Stock-Based Compensation $28M $59M $61M $75M $64M
Change in Accounts Receivable $120M -$85M -$209M -- -$15M
Change in Inventories -- -- -- -- --
Cash From Operations -$611M $315M $674M $800M $633M
 
Capital Expenditures $122M $111M $201M $208M $170M
Cash Acquisitions -$60M -$2.8B -$128M -$211M -$635M
Cash From Investing -$736M -$1.8B $416M -$365M $81M
 
Dividends Paid (Ex Special Dividend) -$20M -- -- -$47M -$60M
Special Dividend Paid
Long-Term Debt Issued $2B $1.9B -- $596M $1.4B
Long-Term Debt Repaid -$406M -$1.2B -$711M -$660M -$750M
Repurchase of Common Stock -$69M -- -$369M -$453M -$1.2B
Other Financing Activities -$15M -$18M -$26M -$14M -$42M
Cash From Financing $1.5B $1.3B -$1.1B -$578M -$618M
 
Beginning Cash (CF) $1.1B $1.2B $1.1B $1.1B $919M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $178M -$169M -$16M -$146M $99M
Ending Cash (CF) $1.2B $1.1B $1.1B $919M $1B
 
Levered Free Cash Flow -$733M $204M $473M $592M $463M
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Net Income to Stockholders -$304M -$73M $58M $522M $24M
Depreciation & Amoritzation $82M $128M $107M $102M $88M
Stock-Based Compensation $32M $31M $31M $31M $31M
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -$91M $180M $225M $242M $153M
 
Capital Expenditures $19M $43M $30M $34M $30M
Cash Acquisitions -$100M -$42M -$156M -$6M -$38M
Cash From Investing -$31M -$110M -$149M $42M $239M
 
Dividends Paid (Ex Special Dividend) -- -- -- -$15M -$14M
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -- $990M
Long-Term Debt Repaid -- -$1M -$14M -$1M -$451M
Repurchase of Common Stock -- -- -$106M -$388M -$149M
Other Financing Activities -$14M -$13M -$13M -$40M -$36M
Cash From Financing -$14M -$14M -$133M -$444M $340M
 
Beginning Cash (CF) $1.2B $1.1B $1.1B $919M $1B
Foreign Exchange Rate Adjustment $5M $5M -$4M -$2M -$8M
Additions / Reductions -$136M $49M -$57M -$160M $732M
Ending Cash (CF) $1.1B $1.1B $1B $760M $1.7B
 
Levered Free Cash Flow -$110M $137M $195M $208M $123M
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Net Income to Stockholders -$904M $9M $586M $684M $798M
Depreciation & Amoritzation $335M $383M $440M $434M $355M
Stock-Based Compensation $43M $58M $61M $75M $64M
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -$602M $586M $719M $817M $544M
 
Capital Expenditures $86M $135M $188M $212M $166M
Cash Acquisitions -$139M -$2.8B -$242M -$61M -$667M
Cash From Investing -$780M -$1.9B $377M -$174M $278M
 
Dividends Paid (Ex Special Dividend) -- -- -- -$62M -$59M
Special Dividend Paid
Long-Term Debt Issued -- -- -- $596M $2.4B
Long-Term Debt Repaid -- -$1.2B -$724M -$647M -$1.2B
Repurchase of Common Stock -- -- -$475M -$735M -$951M
Other Financing Activities -$22M -$17M -$26M -$41M -$38M
Cash From Financing $1.3B $1.3B -$1.2B -$889M $166M
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$124M $16M -$122M -$249M $991M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -$688M $451M $531M $605M $378M
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Net Income to Stockholders -$304M -$73M $58M $522M $24M
Depreciation & Amoritzation $82M $128M $107M $102M $88M
Stock-Based Compensation $32M $31M $31M $31M $31M
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -$91M $180M $225M $242M $153M
 
Capital Expenditures $19M $43M $30M $34M $30M
Cash Acquisitions -$100M -$42M -$156M -$6M -$38M
Cash From Investing -$31M -$110M -$149M $42M $239M
 
Dividends Paid (Ex Special Dividend) -- -- -- -$15M -$14M
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -- $990M
Long-Term Debt Repaid -- -$1M -$14M -$1M -$451M
Repurchase of Common Stock -- -- -$106M -$388M -$149M
Other Financing Activities -$14M -$13M -$13M -$40M -$36M
Cash From Financing -$14M -$14M -$133M -$444M $340M
 
Beginning Cash (CF) $1.2B $1.1B $1.1B $919M $1B
Foreign Exchange Rate Adjustment $5M $5M -$4M -$2M -$8M
Additions / Reductions -$136M $49M -$57M -$160M $732M
Ending Cash (CF) $1.1B $1.1B $1B $760M $1.7B
 
Levered Free Cash Flow -$110M $137M $195M $208M $123M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Berkshire The Best Stock to Buy in a Bad Market?
Is Berkshire The Best Stock to Buy in a Bad Market?

Berkshire Hathaway (NYSE:BRK.A, BRK.B) has historically been one of the…

Is Shopify Stock Still a Buy in 2025 or Has Growth Peaked?
Is Shopify Stock Still a Buy in 2025 or Has Growth Peaked?

The big picture trends in e‑commerce sales are clearly in…

Is RTX The Best Growth Stock?
Is RTX The Best Growth Stock?

Among the worldwide aerospace and defense markets, the US controls…

Stock Ideas

Buy
71
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Sell
40
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 33x

Buy
63
Is NVDA Stock a Buy?

Market Cap: $2.8T
P/E Ratio: 39x

Alerts

Buy
60
RGC alert for May 6

Regencell Bioscience Holdings [RGC] is up 73.72% over the past day.

Buy
63
SKX alert for May 6

Skechers USA [SKX] is down 0.07% over the past day.

Sell
20
PTCT alert for May 6

PTC Therapeutics [PTCT] is down 11% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock